Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Kudos to our much-maligned CEO!
View:
Post by gojotv! on May 03, 2021 6:59pm

Kudos to our much-maligned CEO!

And let that be a lesson to the slanderous gossips and libelos bashers...
NEVER UNDERESTIMATE THE MIND OF A MAN WHO SOUNDS LIKE ALFRED HITCHCOCK!
And now, kindly take your need for fast-talking blabbermouth CEO's elsewhere...
We're busy making money and hunting cancer here!
Three cheers for Tripp!
Comment by Thisguyiscool on May 03, 2021 8:01pm
You mean the guy who did one investor presentation, got the stock to drop from 1.57 to 64 cents along with getting the analyst to downgrade.. booked and canceled the agm, then rescheduled.... The guy who promised 30mill in revenue, the guy who did the incor pharma deal that was a dud.... The guy who didn't deliver on a large healthcare partner... The guy who hasn't given and update since ...more  
Comment by gojotv! on May 03, 2021 9:08pm
This post is so deliciously short-sighted that now I see how I got a hold of about 70,000 shares so easily, hehehe! First, our CEO did not get the stock to drop, that was done by your favourite Clarus analyst, who MISTAKENLY assumed that SZLS is no longer seeking the employer market. And yeah, SZLS made some changes... The thing about being a smaller company in a large pool of established ones is ...more  
Comment by Thisguyiscool on May 04, 2021 1:32am
hahahahhaha... Nice post If only you were able to know just how wrong you are..... Oh well....
Comment by Mermer2328 on May 04, 2021 7:54am
the SP did not drop because of the Analyst downgrade. On April is it dropped by about 40% because of the so called ,half passed Aristotle launch. Way before Noel's downgrade. Get your facts straight before You open your mouth. This new Rexall news might help a bit, but we are after all a cancer company
Comment by gojotv! on May 04, 2021 8:55am
I was there, dude. The Clarus guy put out his analysis on Tuesday, the 6th of April, the day after the Easter weekend. So, the worst of the price drop was indeed caused by his action. I don't count the 11th hour surge to $1.50ish as the "share price". It was just a few people chasing shares while everyone was holding, waiting for news. The REAL share price was in the $1.20-1.30s, and ...more  
Comment by Liked2Think on May 03, 2021 9:42pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities